Moderately Bullish (Medium Term (7.5/10)
Latest Positives
* The company remains the **largest general insurer in India**, with improving market share and strong investment assets under management.
* Valuation is still relatively attractive compared to private peers, trading at a lower P/E than companies like ICICI Lombard, Star Health and Go Digit.
* The insurance sector continues to benefit from increasing insurance penetration and improving premium growth, supporting long-term prospects.
Best Entry
* Ideal accumulation: ₹168-175
* Aggressive buy: Around current levels if the stock holds ₹170 on a weekly closing basis.
* Add more only after a breakout above ₹190 with strong volume.
Stop Loss
* Positional: ₹158
* Conservative: Weekly close below ₹165
Targets
* Target 1: ₹190
* Target 2: ₹215
* Target 3 (6-12 months): ₹240-250
Among listed general insurers, NIACL currently stands out as one of the better value plays, though private insurers continue to command higher valuations because of stronger profitability metrics.
Latest Positives
* The company remains the **largest general insurer in India**, with improving market share and strong investment assets under management.
* Valuation is still relatively attractive compared to private peers, trading at a lower P/E than companies like ICICI Lombard, Star Health and Go Digit.
* The insurance sector continues to benefit from increasing insurance penetration and improving premium growth, supporting long-term prospects.
Best Entry
* Ideal accumulation: ₹168-175
* Aggressive buy: Around current levels if the stock holds ₹170 on a weekly closing basis.
* Add more only after a breakout above ₹190 with strong volume.
Stop Loss
* Positional: ₹158
* Conservative: Weekly close below ₹165
Targets
* Target 1: ₹190
* Target 2: ₹215
* Target 3 (6-12 months): ₹240-250
Among listed general insurers, NIACL currently stands out as one of the better value plays, though private insurers continue to command higher valuations because of stronger profitability metrics.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.